000 01728 a2200505 4500
005 20250515060206.0
264 0 _c20070628
008 200706s 0 0 eng d
022 _a0923-7534
024 7 _a10.1093/annonc/mdl495
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCalvo, E
245 0 0 _aAssessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancer.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cApr 2007
300 _a761-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCarcinoma, Squamous Cell
_xchemistry
650 0 4 _aCyclin-Dependent Kinase Inhibitor p27
_xanalysis
650 0 4 _aErbB Receptors
_xanalysis
650 0 4 _aErlotinib Hydrochloride
650 0 4 _aExtracellular Signal-Regulated MAP Kinases
_xanalysis
650 0 4 _aFemale
650 0 4 _aHead and Neck Neoplasms
_xchemistry
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aQuinazolines
_xadverse effects
650 0 4 _aSkin
_xdrug effects
700 1 _aMalik, S N
700 1 _aSiu, L L
700 1 _aBaillargeon, G M
700 1 _aIrish, J
700 1 _aChin, S F
700 1 _aSantabarbara, P
700 1 _aKreisberg, J I
700 1 _aRowinsky, E K
700 1 _aHidalgo, M
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 18
_gno. 4
_gp. 761-7
856 4 0 _uhttps://doi.org/10.1093/annonc/mdl495
_zAvailable from publisher's website
999 _c16875892
_d16875892